Rick E. Winningham - Nov 19, 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Corinna Liebowitz, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Nov 19, 2025
Transactions value $
-$1,017,024
Form type
4
Date filed
11/21/2025, 07:10 PM
Previous filing
Nov 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Winningham Rick E CHIEF EXECUTIVE OFFICER, Director C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO /s/ Corinna Liebowitz, Attorney-in-Fact 2025-11-21 0001302443

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Gift $0 -9.9K -0.58% $0.00 1.71M Nov 19, 2025 Direct F1
transaction TBPH Ordinary Shares Gift $0 +9.9K +73.33% $0.00 23.4K Nov 19, 2025 As Custodian F1, F2
transaction TBPH Ordinary Shares Tax liability -$1.02M -56.8K -3.33% $17.90 1.65M Nov 20, 2025 Direct F3
holding TBPH Ordinary Shares 92.6K Nov 19, 2025 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.
F2 The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.
F3 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.